ARTICLES BY THIS AUTHOR

• 4/14/2016

  Big jump in migration of Quebec family doctors from public to private

• 4/14/2016

  Doctors come to the defence of former head of cardiology association in CPSO hearing

• 4/13/2016

  Legislation mandates both nurse practitioners and MDs to provide assisted death

• 4/13/2016

  The doctor’s friend: the CMPA

• 4/13/2016

  P.E.I. may soon disclose the names and salaries of certain doctors

• 4/13/2016

  Two physicians allege private clinic gave preferential treatment to fee-paying patients

  Alberta auditing clinic after a lawsuit launched by two former physicians contained number of striking allegations
• 4/13/2016

  Q&A: Sandra Martin on how to legislate doctor-assisted death

  The author of ‘A Good Death’ looks at right-to-die legislation around the world—and how the issue has evolved in Canada
• 4/12/2016

  Case Study: How incorporated MDs may be affected by changes to the small business deduction

• 4/12/2016

  Policy makers and doctors struggle to respond to study on gender-selective abortions

  CMAJ study found that abortion rates among Indian women with two daughters rose during the third pregnancy
• 4/12/2016

  Drug-coated balloons and the evolving landscape of peripheral artery disease

  An increase in both prevalence and awareness of peripheral artery disease now places increased pressure on researchers, clinicians, and medical facilities to identify and employ more efficacious and efficient treatment methodologies. The global market for devices used to treat PAD is being driven by significant demographic shifts, most of which are being mirrored by the Canadian experience.